Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

168.16
-0.6500-0.39%
Post-market: 168.08-0.0800-0.05%19:57 EDT
Volume:11.12M
Turnover:1.86B
Market Cap:43.39B
PE:-11.83
High:168.51
Open:168.23
Low:165.19
Close:168.81
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:1.37
T/O Rate:4.31%
Dividend:2.55
Dividend Rate:1.52%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.26
PE(LYR):-11.83

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Oct 03

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Oct 03

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Oct 03

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

TIPRANKS
·
Oct 03

What Ryman Healthcare's 39% Fall Still Teaches You About Turnarounds

Simply Wall St.
·
Oct 03

Alliance Healthcare Turns Investment Phase Into Profit as Managed Care Scales Up

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)

TIPRANKS
·
Oct 02

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Jobs Data

MT Newswires Live
·
Oct 02

Analyst Initiates Buy on GPI, Citing Strong Earnings Quality, Margin Resilience and Long-Term Growth Visibility in Software and Healthcare Solutions

TIPRANKS
·
Oct 02

Health Care Select Sector SPDR: Pivot points

TIPRANKS
·
Oct 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Oct 02

Correction: Top Midday Decliners

MT Newswires Live
·
Oct 02

Piper Sandler Remains a Buy on Shattuck Labs (STTK)

TIPRANKS
·
Oct 02

Piper Sandler Remains a Buy on Regeneron (REGN)

TIPRANKS
·
Oct 02

EPF Raises Stake in IHH Healthcare to 13.245%

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)

TIPRANKS
·
Oct 02

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

TIPRANKS
·
Oct 02

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

Reuters
·
Oct 02

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS
·
Oct 02